ArticleCardiovascular drugs and therapy2026
Dexmedetomidine Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting DNMT3B-Mediated Hypermethylation of the KLF4 Promoter.
XinJing Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.